Chronic Morphine-Induced Changes in Signaling at the A3Adenosine Receptor Contribute to Morphine-Induced Hyperalgesia, Tolerance, and Withdrawal
| العنوان: | Chronic Morphine-Induced Changes in Signaling at the A3Adenosine Receptor Contribute to Morphine-Induced Hyperalgesia, Tolerance, and Withdrawal |
|---|---|
| المؤلفون: | Zhoumou Chen, Kenneth A. Jacobson, Vasiliki Staikopoulos, Todd W Vanderah, Gary J. Bennett, Dilip K. Tosh, Rebecca Dalgarno, Daniela Salvemini, Tuan Trang, Mark R. Hutchinson, Churmy Fan, Timothy M. Doyle, Salvatore Cuzzocrea, Emanuela Esposito, Tally M. Largent-Milnes |
| المصدر: | Journal of Pharmacology and Experimental Therapeutics. 374:331-341 |
| بيانات النشر: | American Society for Pharmacology & Experimental Therapeutics (ASPET), 2020. |
| سنة النشر: | 2020 |
| مصطلحات موضوعية: | 0301 basic medicine, Pharmacology, Agonist, biology, medicine.drug_class, business.industry, Adenosine kinase, Adenosine, Adenosine receptor, ADK, Analgesics, Animals, Female, Hyperalgesia, Interleukin-10, Interleukin-1beta, Male, Morphine, Rats, Rats, Sprague-Dawley, Receptor, Adenosine A3, Signal Transduction, Substance Withdrawal Syndrome, Time Factors, Drug Tolerance, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Nociception, Neuropathic pain, medicine, biology.protein, Molecular Medicine, medicine.symptom, business, 030217 neurology & neurosurgery, medicine.drug |
| الوصف: | Treating chronic pain using opioids, such as morphine, is hampered by the development of opioid-induced hyperalgesia (OIH; increased pain sensitivity), antinociceptive tolerance and withdrawal which can contribute to dependence and abuse. In the central nervous system, the purine nucleoside adenosine has been implicated in beneficial and detrimental actions of morphine, but the extent of their interaction remains poorly understood. Here, we demonstrate that morphine-induced OIH and antinociceptive tolerance in rats is associated with a 2-fold increase in adenosine kinase (ADK) expression in the dorsal horn of the spinal cord (DH-SC). Blocking ADK activity in the spinal cord provided greater than 90% attenuation of OIH and antinociceptive tolerance through A3 adenosine receptor (A3AR) signaling. Supplementing adenosine signaling with selective A3AR agonists blocked OIH and antinociceptive tolerance in rodents of both sexes. Engagement of A3AR in the spinal cord with an ADK inhibitor or A3AR agonist was associated with reduced DH-SC expression of the NOD-like receptor pyrin domain-containing 3 (NLRP3; 60-75%), cleaved caspase 1 (40-60%), interleukin (IL)-1β (76-80%) and tumor necrosis factor (TNF; 50-60%). In contrast, the neuroinhibitory and anti-inflammatory cytokine IL-10 increased 2-fold. In mice, A3AR agonists prevented the development of tolerance in a model of neuropathic pain and reduced naloxone-dependent withdrawal behaviors by greater than 50%. These findings suggest A3AR-dependent adenosine signaling is compromised during sustained morphine to allow the development of morphine-induced adverse effects. These findings raise the intriguing possibility that A3AR agonists may be useful adjunct to opioids to manage their unwanted effects. |
| تدمد: | 1521-0103 0022-3565 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78e5c72de91dfcafafb9456e74601105 https://doi.org/10.1124/jpet.120.000004 |
| حقوق: | OPEN |
| رقم الأكسشن: | edsair.doi.dedup.....78e5c72de91dfcafafb9456e74601105 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 15210103 00223565 |
|---|